HEPION PHARMS INC (HEPA) Total Assets by Year
HEPION PHARMS INC closed fiscal year 2025 with $3.1M in total assets, $402K in total liabilities and $2.7M in shareholder equity. This represents an increase of 90.2% from the prior fiscal year. The table below carries 13 fiscal years, from 2014 to 2025, and the quarters HEPION PHARMS INC has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
HEPA Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1410-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.1M+90.2% | $1.6M-91.1% | $18.1M-70.0% | $60.2M-41.8% | $103.6M+112.9% | $48.6M+136.0% | $20.6M+151.7% | $8.2M-55.5% | $18.4M+40.3% | $13.1M+143.7% | $5.4M+168.7% | $2.0M | $2.6M |
| Total Liabilities | $402K-88.4% | $3.5M-67.8% | $10.8M+4.1% | $10.4M-1.6% | $10.6M+29.9% | $8.1M+62.7% | $5.0M-19.6% | $6.2M-33.4% | $9.3M-20.9% | $11.8M+508.3% | $1.9M-60.7% | $4.9M | $10.0M |
| Total Equity | $2.7M+243.2% | -$1.9M-125.6% | $7.3M-85.4% | $49.9M-46.4% | $93.0M+129.5% | $40.5M+159.5% | $15.6M+805.4% | $1.7M-81.0% | $9.1M+587.5% | $1.3M-61.7% | $3.4M+217.2% | -$2.9M | -$7.3M |
HEPA Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.9M-57.2% | $2.7M-57.2% | $3.1M+90.2% | $3.7M+0.7% | $4.5M-25.0% | $6.3M-60.5% | $1.6M-91.1% | $3.7M-85.1% | $6.0M-83.5% | $16.0M-67.7% | $18.1M-70.0% | $25.0M-64.1% |
| Total Liabilities | $649K-8.4% | $849K-65.0% | $402K-88.4% | $416K-89.9% | $709K-71.1% | $2.4M-71.4% | $3.5M-67.8% | $4.1M-53.4% | $2.4M-75.8% | $8.5M-31.4% | $10.8M+4.1% | $8.8M-15.3% |
| Total Equity | $1.3M-66.3% | $1.9M-52.3% | $2.7M+243.2% | $3.3M+717.4% | $3.8M+6.6% | $3.9M-48.2% | -$1.9M-125.6% | $407K-97.5% | $3.6M-86.5% | $7.5M-79.8% | $7.3M-85.4% | $16.2M-72.7% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More HEPION PHARMS INC financials
Frequently Asked Questions
What was HEPION PHARMS INC's total assets in fiscal year 2025?
HEPION PHARMS INC closed fiscal year 2025 with $3.1M in total assets, $402K in total liabilities and $2.7M in shareholder equity.
How fast is HEPION PHARMS INC's total assets growing?
HEPION PHARMS INC (HEPA) total assets rose by 90.2% year over year, from $1.6M to $3.1M in fiscal year 2025.
How has HEPION PHARMS INC's total assets changed over the years?
Across the 13 fiscal years this page covers, HEPION PHARMS INC (HEPA) total assets went from $2.6M in fiscal year 2014 to $3.1M in fiscal year 2025.
What was HEPION PHARMS INC's total assets in the most recent quarter?
HEPION PHARMS INC (HEPA) reported $1.9M in total assets in Q2 2026. This represents a decrease of 57.2% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what HEPION PHARMS INC (HEPA) reported on that line in every period on record.